Th17 and Th1 T-Cell Responses in Giant Cell Arteritis
Author(s) -
Jiusheng Deng,
Brian R. Younge,
Richard A. Olshen,
Jörg J. Goronzy,
Cornelia M. Weyand
Publication year - 2010
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.109.872903
Subject(s) - medicine , giant cell arteritis , glucocorticoid , inflammation , immunology , flow cytometry , vasculitis , arteritis , systemic vasculitis , systemic inflammation , interferon , interleukin 17 , pathology , disease
In giant cell arteritis (GCA), vasculitic damage of the aorta and its branches is combined with a syndrome of intense systemic inflammation. Therapeutically, glucocorticoids remain the gold standard because they promptly and effectively suppress acute manifestations; however, they fail to eradicate vessel wall infiltrates. The effects of glucocorticoids on the systemic and vascular components of GCA are not understood.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom